Literature DB >> 17553644

Interleukin-6 attenuates hyperthermia-induced seizures in developing rats.

Mitsumasa Fukuda1, Takehiko Morimoto, Yuka Suzuki, Chiya Shinonaga, Yasushi Ishida.   

Abstract

Previous studies indicated that several cytokines influenced the seizure propensity in convulsive disorders and were the cause of encephalopathies in childhood. We studied the role of one inflammatory cytokine, interleukin-6 (IL-6), in hyperthermia-induced seizures in developing rats. Twenty-four male Lewis rats (23-28 days old) were divided into three groups (n=8/IL-6 (500 ng), IL-6 (50 ng), and saline control groups). We applied human recombinant IL-6 intra-nasally to developing rats 1h before seizures induced by moist heated air (50 degrees C). The seizure latency was defined as the time from hyperthermia onset until the appearance of continuous seizure discharges on electroencephalography (EEG), and the seizure duration as the duration of continuous spike and wave discharges on EEG. Five of the eight rats in the IL-6 (500 ng) group, two in the IL-6 (50 ng) group, and one in the control group exhibited no seizure discharges during the 360 s heating period. In these cases, the seizure latency time was regarded as 360 s and the seizure duration time as 0 s. The median seizure latency for the IL-6 (500 ng) group, 360 s (range: 256-360), was significantly longer than that for the control one, 249 (121-360) (P<0.05). The seizure duration for the IL-6 (500 ng) group, 0 s (0-20), was significantly shorter than that for the control one, 33 (0-76) (P<0.025). Also, the adenosine receptor antagonist, aminophylline, prevented these effects of IL-6 on hyperthermia-induced seizures. These results indicate that IL-6 plays an anti-convulsive role through the adenosine system in hyperthermia-induced seizures, which might be relevant as to human febrile seizures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553644     DOI: 10.1016/j.braindev.2007.04.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

Review 1.  IL-1β: an important cytokine associated with febrile seizures?

Authors:  Hong-Mei Yu; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

2.  Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.

Authors:  Dipan C Patel; Karen S Wilcox; Cameron S Metcalf
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

3.  High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats.

Authors:  Masanori Ito; Hisaaki Takahashi; Hajime Yano; Yusuke I Shimizu; Yoshiaki Yano; Yoshito Ishizaki; Junya Tanaka; Eiichi Ishii; Mitsumasa Fukuda
Journal:  Metab Brain Dis       Date:  2017-09-06       Impact factor: 3.584

Review 4.  Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.

Authors:  Alireza Soltani Khaboushan; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

Review 5.  Fever, febrile seizures and epilepsy.

Authors:  Céline M Dubé; Amy L Brewster; Cristina Richichi; Qinqin Zha; Tallie Z Baram
Journal:  Trends Neurosci       Date:  2007-09-25       Impact factor: 13.837

6.  Interleukin-6 gene polymorphisms in Egyptian children with febrile seizures: a case-control study.

Authors:  Seham F Azab; Mohamed A Abdalhady; Alshaymaa Ali; Ezzat K Amin; Dina T Sarhan; Eman M Elhindawy; Mohamed A A Almalky; Ahmed A Elhewala; Mohamed M A Salam; Mustafa I A Hashem; Attia A Soliman; Nagwa E Akeel; Sawsan H Abdellatif; Sanaa M Ismail; Nahla A Elsamad; Manal S Arafat; Anwar A Rass; Maha A A Basset
Journal:  Ital J Pediatr       Date:  2016-03-09       Impact factor: 2.638

7.  Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model.

Authors:  Seon-Ah Chong; Silvia Balosso; Catherine Vandenplas; Gregory Szczesny; Etienne Hanon; Kasper Claes; Xavier Van Damme; Bénédicte Danis; Jonathan Van Eyll; Christian Wolff; Annamaria Vezzani; Rafal M Kaminski; Isabelle Niespodziany
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

8.  Effect of topiramate on interleukin 6 expression in the hippocampus of amygdala-kindled epileptic rats.

Authors:  Fei Ye; Xu-Qin Chen; Guan-Shui Bao; Yin Hua; Zhe-Dong Wang; Yi-Chuan Bao
Journal:  Exp Ther Med       Date:  2013-11-08       Impact factor: 2.447

9.  Serum and CSF adiponectin, leptin, and interleukin 6 levels as adipocytokines in Egyptian children with febrile seizures: a cross-sectional study.

Authors:  Seham F Azab; Mohamed A Abdalhady; Mohamed A A Almalky; Ezzat K Amin; Dina T Sarhan; Eman M Elhindawy; Mayy A N Allah; Ahmed A Elhewala; Mohamed M A Salam; Mustafa I A Hashem; Attia A Soliman; Nagwa E Akeel; Sawsan H Abdellatif; Nahla A Elsamad; Anwar A Rass; Manal S Arafat
Journal:  Ital J Pediatr       Date:  2016-04-12       Impact factor: 2.638

10.  A Prospective Study of Novel Therapeutic Targets Interleukin 6, Tumor Necrosis Factor α, and Interferon γ as Predictive Biomarkers for the Development of Posttraumatic Epilepsy.

Authors:  Ajay Choudhary; Rahul Varshney; Ashok Kumar; Kaviraj Kaushik
Journal:  World Neurosurg X       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.